International

In recent years, Barclay Pharmaceuticals Laboratories has undergone rapid and significant geographical expansion, managed from our global headquarters in the United Kingdom.In recent years, Barclay Pharmaceuticals Laboratories has experienced rapid and substantial geographical growth, all directed from our global headquarters in the United Kingdom. This expansion reflects our commitment to reaching more patients worldwide and ensuring that our innovative therapies are accessible regardless of location. Today, 80% of our business operations are conducted outside the United States, highlighting our success in entering new markets and expanding our global footprint. We remain dedicated to our mission of making our medical expertise and therapeutic solutions available to patients everywhere, continually striving to bridge gaps in healthcare access and improve patient outcomes around the globe.

80% of our business now sits outside the US and we continue to strive to make our therapies and expertise available to patients wherever they are in the world.

Since 2018, our presence has expanded to over 30 markets worldwide, including key regions such as the United States, the European Union, and Japan. Our growth is driven by an ever-expanding network of affiliates and partners, allowing us to maximize our global reach and bring our services to new communities.

To ensure sustainable expansion, we are committed to developing and replicating our support networks in every new market we enter. This involves training nurses, educating local healthcare teams, and providing continuous support in the latest technologies and specialized care techniques. By doing so, we empower local healthcare providers to deliver the highest quality care tailored to their specific needs.

In addition, we actively participate in global neurology conferences and symposia. Through these platforms, we aim to foster international collaboration, enhance understanding of our targeted disease areas, and increase awareness of our innovative therapies. Our involvement in these events allows us to contribute to the global conversation on neurological healthcare and reinforce our commitment to advancing patient care worldwide.

To make our expansion sustainable, we continue to develop and replicate our support network in new markets, training nurses and educating local healthcare teams on evolving technologies and specialist care.

We are also active at global neurology conferences and symposia to help advance international understanding of our disease areas and build awareness around our therapies.